News

Ideas That Generate Results

Driven by factors, such as increasing prevalence of chronic diseases, rising demand for POCT and technological advancements in the global market, the IVD market is going through a very exciting phase. Presently, the market is dominated by developed countries; however, rising economies such as India, Brazil and China are likely to witness strong growth in the coming years.
 
In the latest research study, “In-Vitro Diagnostics Market Outlook 2018”, RNCOS analysts identified market dynamics in various important regions to highlight the areas offering promising possibilities for companies to boost their growth. The market, which stood at US$ 55.4 Billion in 2013, is expected to grow at a CAGR of around 7% during 2013-2018.
 
The market has been segmented keeping in mind three factors: Clinical use, Geographical scenario and Player specializations, and for every segment a current and future outlook to 2018 has been provided. For regional analysis, key IVD markets that together constitute around 95% of the global market, have been profiled. Through this research, opportunity assessment in various segments has been performed and the segments that offer the maximum opportunity for growth have been highlighted.
 
The study further delves into the business dynamics of major players in the industry that together form around 70% of the global IVD market. To provide a thorough understanding of the Company’s business model, Company’s current and historical financials have been analyzed. Also, the Company’s revenue from IVD has been depicted, with a further breakup by clinical segment. The study also portrays some of the profiled Company’s strengths and weaknesses that will help the reader to better position their company vis-à-vis competition.
 
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM679.htm
 
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm